Sangamo Announces ASGCT 2024


Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results

Conference call and webcast scheduled for Tuesday, August 8 , 4:30 p.m. Eastern Time . BRISBANE, Calif. --(BUSINESS WIRE)--Aug. 8, 2023-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and second quarter 2023 financial results.